Biossom Investment Management (崇德弘信) is a venture capital fund that focuses on investments in the bio-pharmaceuticals industry.
Phone: +86 010-59773801
5th Floor, Building 2, Aipuyi Building
No. 1, Disheng East Road, Beijing Economic and Technological Development Zone
Beijing, 100176
Beijing, China
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-04-11 | ImmuneOnco Biopharma | Series A | $15.95M | Lang Sheng Investment, Longpan Investment, Smilestone, Yaluo Investment, and Z&H Investment |
| 2018-01-31 | SENYINT | Series D | Guochuang Investment, Hainan Haiyao, Jinmao Capital, Lianrun Dongfang Investment, Sensegain Asset Management, Tenyall, Tianxing Capital, Xianchuang Investment, and Youwin Capital | |
| 2017-05-23 | CANbridge Life Sciences | Series B | $25M | Lapam Capital, Qiming Venture Partners, WuXi AppTec, Yanyuan Capital, and YuanMing Capital |
